PHENELZINE SULFATE

Post-LOE

phenelzine sulfate

Pfizer

ANDAORALTABLET

Approved

Dec 2010

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

5/8 — Partial

PHENELZINE SULFATE (phenelzine sulfate) by Pfizer is clinical pharmacology monoamine oxidase is a complex enzyme system, widely distributed throughout the body. Approved for anxiety, depression. First approved in 2010.

Drug data last refreshed 19h ago

$0.0BPart D

Mechanism of Action

CLINICAL PHARMACOLOGY Monoamine oxidase is a complex enzyme system, widely distributed throughout the body. Drugs that inhibit monoamine oxidase in the laboratory are associated with a number of clinical effects. Thus, it is unknown whether MAO inhibition per se, other pharmacologic actions, or an…

Indications (2)

anxiety

Worked on PHENELZINE SULFATE at Pfizer? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Clinical Trials (1)

NCT01253642Phase 2Terminated

Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel

Started Jul 2010

11 enrolled

Hormone-Resistant Prostate CancerMetastatic Prostatic AdenocarcinomaProstate Adenocarcinoma+1 more